2981 - 2990 of 8654 Results
Title
Year
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
-
OPENTitle: STEP61is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 4Start Page: 1202End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1417423112Best OA location URL: https://www.pnas.org/content/pnas/112/4/1202.full.pdfCitation Count: 59
-
OPENTitle: Human pericytes degrade diverse α-synuclein aggregatesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 11Start Page: e0277658End Page: e0277658Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0277658Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277658&type=printableCitation Count: 14
-
OPENTitle: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effectJournal Name: Physical BiologyPublisher: IOP PublishingVol: 18Issue #: 1Start Page: 016002End Page: 016002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1478-3975/abb6dcBest OA location URL: https://iopscience.iop.org/article/10.1088/1478-3975/abb6dc/pdfCitation Count: 18
-
RESTRICTEDTitle: The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 4Start Page: 463End Page: 465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.005Citation Count: 1
-
RESTRICTEDTitle: High-Throughput Extracellular Vesicle Isolation Using Plate-Based Size Exclusion Chromatography and AutomationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jacs.4c17948Citation Count: 0
-
OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 17
-
OPENTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6123262Citation Count: 132
-
OPENTitle: Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 3Start Page: 960End Page: 975Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaa020Best OA location URL: https://doi.org/10.1093/brain/awaa020Citation Count: 75
-
OPENTitle: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communitiesJournal Name: Preventive MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6354577Citation Count: 41